TechHereditary screening company checks out alternatives in the middle of monetary concerns by The Tamesis When worth $ 6 billion, the marketplace worth of 23andme is currently much less than $ 100 million. Post Views: 103 Share this Facebook X Telegram Whatsapp Email TagsexploresFinancialfirmgeneticissuesoptionstestingRelated Posts Seoul Firm Puts Humanoids on Catwalk May 29, 2026 The Social Entrepreneurs Tackling Issues From Food Waste To Inequality May 28, 2026 New weight-loss drug Retatrutide showing stronger results than current options May 22, 2026 The TamesisLeave a Reply Cancel replyYour email address will not be published. Save my name, email, and website in this browser for the next time I comment. Previous StoryGoogle staff members application for task protection in the middle of cuts run the risk of Next StoryNephrology and urology tools market to strike $39.3 b by 2030 Latest from Blog What Was Nigeria’s Osogbo School of Art, and Why Was It So Important? by The Tamesis Meryll Rogge and Stefano Rosso on Marni’s New Era by The Tamesis Campaigns offer differing views on record early voting – Asia News Network by The Tamesis ‘Euphoria’: 50 Thoughts I Had About the Season 3 Finale by The Tamesis 9 Best Korean Vitamin C Serums to Brighten Skin by The Tamesis Interplay of parties, monarchy in Malaysian politics – Asia News Network by The Tamesis The Japanese Towel Roll Is Here to Fix Your Posture by The Tamesis What K-Pop Can Teach Every Business About Market Creation by The Tamesis Dua Lipa’s Wedding Skirt Suit Pays Homage to the Original Cool Girl Bride by The Tamesis Florence Pugh Embraces Her Boho-iest Glam Yet—and Uses Real Flowers To Do It by The TamesisRelated Posts Seoul Firm Puts Humanoids on Catwalk May 29, 2026 The Social Entrepreneurs Tackling Issues From Food Waste To Inequality May 28, 2026 New weight-loss drug Retatrutide showing stronger results than current options May 22, 2026 Previous StoryGoogle staff members application for task protection in the middle of cuts run the risk of Next StoryNephrology and urology tools market to strike $39.3 b by 2030